Proteomics International Laboratories has launched its breakthrough PromarkerD predictive test for diabetic kidney disease (DKD) in Australia.
The test will be wheeled out to doctors in Western Australia and the Northern Territory first before going nationwide.
In an exercise of good timing, the launch was planned to coincide with World Kidney Day, which the company says will help spotlight the product as a significant addition to a health professional’s armoury. It comes as the industry promotes the importance of early detection and intervention in kidney disease.
